pre-IPO PHARMA

pre-IPO PHARMA NEWS


Business

phosplatin-therapeutics

05/05/22

Phosplatin Therapeutics Adopts New Corporate Name as Promontory Therapeutics Inc.

flare-therapeutics

05/05/22

Flare Therapeutics to Present at the Bank of America Securities 2022 Healthcare Conference

curebase

05/05/22

Curebase Secures $40 Million in Series B Funding


enteris-biopharma

05/04/22

Enteris BioPharma to Exhibit at CPhI North America 2022

apnimed

05/04/22

Apnimed Announces $62.5 Million Series C Financing to Advance Development of Novel Pharmaceutical Treatments for Obstructive Sleep Apnea (OSA) and Related Sleep Disorders

alamar-biosciences

05/04/22

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

tevogen-bio

05/03/22

Tevogen Bio Expands Research and Development Capacity at CIC Philadelphia to Accommodate its Expanding Product Portfolio

nikang-therapeutics

05/03/22

NiKang Therapeutics and Hansoh Pharma Announce Strategic Collaboration and License Agreement for NKT2152 in Greater China

lutris-pharma

05/03/22

Lutris Pharma to Present at the Bio€quity Europe Conference USA - English USA - English USA - English

genesis-therapeutics

05/03/22

Genesis Therapeutics Announces Strategic Collaboration with Lilly to Discover Novel Therapies Using the Genesis Molecular AI Platform

depymed

05/03/22

DepYmed Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Its Lead Clinical Candidate for the Treatment of Rett Syndrome

complement-therapeutics

05/03/22

Dianthus Therapeutics Launches with $100M to Develop Selective Antibody Complement Therapeutics to Treat Severe and Rare Autoimmune Diseases

arbor-biotechnologies

05/03/22

Arbor Biotechnologies to Present at the Bank of America Global Healthcare Conference

adiso-therapeutics

05/03/22

Adiso Therapeutics to Present at BioNJ's 12th Annual BioPartnering Conference

scribe-therapeutics

05/02/22

Scribe Therapeutics Expands Collaboration With Biogen to Second Target

nevakar

05/02/22

Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar

biocytogen

04/29/22

Biocytogen Enters into Antibody Agreement with Merck KGaA, Darmstadt, Germany

mycovia-pharmaceuticals

04/28/22

FDA Approves Mycovia Pharmaceuticals’ VIVJOA™ (oteseconazole), the First and Only FDA-Approved Medication for Recurrent Vulvovaginal Candidiasis (Chronic Yeast Infection)

myeloid-therapeutics

04/27/22

Myeloid Therapeutics to Participate in Morgan Stanley Private Company Biotech Corporate Access Day

cytovia-therapeutics

04/27/22

Cellectis reçoit une note convertible de 20 millions de dollars dans le cadre de l’accord de collaboration avec son partenaire Cytovia Therapeutics

Science


nkgen-biotech

05/05/22

NKGen Biotech to Present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting

metagenomi

05/05/22

Metagenomi to Present New Preclinical Data at the Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

medicago

05/05/22

Medicago Announces Publication of Phase 3 COVID-19 Vaccine Study Results in New England Journal of Medicine

coda-biotherapeutics

05/05/22

CODA Biotherapeutics Announces Preclinical Data From Epilepsy Program to be Presented at American Society of Gene and Cell Therapy 25th Annual Meeting

starton-therapeutics

05/04/22

Starton Therapeutics Provides Update on STAR-LLD Lenalidomide Clinical Program

melt-pharmaceuticals

05/04/22

Melt Pharmaceuticals Announces MELT-210 Top-Line Results of Phase 1 Pharmacokinetics (PK) Study for Procedural Sedation

elevatebio

05/04/22

ElevateBio Announces Presentation on Lentiviral Vector Platform at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

recode-therapeutics

05/03/22

ReCode Therapeutics to Present Preclinical Data Using Proprietary SORT LNP Delivery Platform From Its mRNA-based Therapeutic Programs at the ATS 2022 International Conference in San Francisco

nanology

05/03/22

NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of its Topical Investigational Drug in the Treatment of Cutaneous Metastases of Breast Cancer


metagenomi

05/03/22

Metagenomi Presents Findings on Novel Families of Ultra Small, CRISPR Enzymes at the Keystone Symposia Precision Genome Engineering Conference

lexeo-therapeutics

05/03/22

LEXEO Therapeutics Announces Data Presentations at the 25th American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

avilar-therapeutics

05/03/22

Avilar Therapeutics Executives to be Featured Speakers on Advances in Protein Degradation at Upcoming Drug Discovery Conferences

acelyrin

05/03/22

ACELYRIN, INC., Affibody AB, and Inmagene Bio Announce Positive Results from Global Phase 2 Trial of Izokibep in Patients with Psoriatic Arthritis

therapeutic-solutions-international

05/02/22

Therapeutic Solutions International Announces Launching of Phase III Clinical Trial for Treating COVID-19 Lung Damage Using its JadiCell™ Universal Donor Stem Cell Drug

orna-therapeutics

05/02/22

Orna Therapeutics to Present Novel, First-in-Class Circular RNA Data at Upcoming ASGCT 2022 Annual Meeting

nkgen-biotech

05/02/22

NKGen Biotech Announces Three SNK01 Abstracts to be Presented at the 2022 ASCO Annual Meeting

forge-biologics

05/02/22

Forge Biologics Announces 7 Presentations at the Upcoming Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

edigene

05/02/22

EdiGene to Present getools, a Data Analysis Software Toolkit for Advanced Analytics of DNA and RNA Editing Efficiency and Outcomes for Therapeutic Development at the ASGCT 25th Annual Meeting

cero-therapeutics

05/02/22

CERo Therapeutics’ Multifunctional CER T Cells Synergize with Standard-of-Care Small Molecule Anti-Tumor Inhibitors Across Hematologic and Solid Tumor Models

catamaran-bio

05/02/22

Catamaran Bio to Present Preclinical Data at ASGCT Annual Meeting to Support CAR-NK Approach for Solid Tumors

People

artiva-biotherapeutics

05/05/22

Artiva Biotherapeutics Appoints Edith A. Perez, M.D., to Its Board of Directors and Clinical Advisory Board


linkinvax

05/04/22

LinKinVax Appoints Dr. Jiong Ma as Independent Board Member


anji-pharma

05/04/22

Julianne Averill and Kristen Richardson Join Anji Pharma to Ready Company for Next Stage of Growth


seismic-therapeutic

05/03/22

Seismic Therapeutic Appoints Maude Tessier, PhD, as Chief Business Officer


curebase

05/03/22

Curebase Named Honorable Mention in Best World Changing Idea NA Category of Fast Company's 2022 World Changing Ideas Awards


ventus-therapeutics

05/02/22

Ventus Therapeutics Appoints Stuart Green, M.D., as Chief Medical Officer



briori-biotech

05/02/22

Gordon Robert Alton, PhD Joins BriOri BioTech as COO to Develop Patented Topical Formulation of Vioxx Providing Those Suffering with Osteoarthritis a Long Lasting Non-Opioid Option for Pain Relief


catamaran-bio

04/27/22

Catamaran Bio Appoints Cherry Thomas, MD, as Chief Medical Officer


vedere-bio

04/26/22

Vedere Bio II Appoints Accomplished Clinician and Researcher Anna-Maria Demetriades as Chief Medical Officer


rome-therapeutics

04/26/22

ROME Therapeutics Appoints Nurjana Bachman, Ph.D., as Senior Vice President, Corporate Development and Strategy


flare-therapeutics

04/26/22

Flare Therapeutics Appoints Adrian Jubb as Chief Medical Officer


adaptive-phage-therapeutics

04/26/22

Adaptive Phage Therapeutics Appoints Rob Casper as Vice President of Clinical Operations


rayzebio

04/25/22

RayzeBio Appoints Angie You, Ph.D., to its Board of Directors


carisma-therapeutics

04/25/22

Carisma Therapeutics Announces Appointment Of Michael Klichinsky, PharmD, PhD, As Chief Scientific Officer


bioTheryX

04/25/22

Biotheryx Announces Appointment of Jeff Caravella as Chief Financial Officer


affyimmune-therapeutics

04/25/22

AffyImmune Therapeutics Announces Hiring of Dr. Sonal Gupta as Senior Vice President and Head of Clinical Development


maxwell-biosciences

04/21/22

Maxwell Biosciences Announces the Appointment of Edward Rudnic, Ph.D., as Chief Operating Officer


ambys-medicines

04/20/22

Ambys Medicines Expands Leadership Team with Key Appointments in Human Resources and Finance Functions


vaxxas

04/20/22

Vaxxas Announces Appointment of Scott Fry Ph.D. as Chief Operating Officer


omniose

04/19/22

Omniose Announces Expanded Leadership Team to Develop Bioconjugate Vaccines Against Serious Bacterial Threats


egenesis

04/19/22

eGenesis Promotes Michael Curtis, Ph.D., to Chief Executive Officer


turnstone-biologics

04/19/22

Turnstone Biologics Announces Executive Leadership Appointments